OTC · LFPI
LifePoint, Inc.
$0.00$0.00 (0.0%)
LifePoint, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
Loading market information…
OTC · LPTI · USD
Stock price, dividends
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
Longport, Inc. focuses on the creation, production, promotion, and distribution of advanced high-resolution ultrasound imaging equipment. Although its primary market is the United States, the company also engages in international exports. A notable product is the EPISCAN I-200, a high-frequency ultrasound system designed to visualize the skin and underlying soft tissue using frequencies ranging from 20 to 50 MHz. These versatile devices are utilized across numerous medical and other domains, including the evaluation and prevention of wounds, clinical dermatology, aesthetic and plastic surgery, burn assessment, superficial musculoskeletal imaging, and veterinary applications. Established in 1993, Longport, Inc. is headquartered in Chadds Ford, Pennsylvania.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:17 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
$0.00$0.00 (0.0%)
LifePoint, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
ViewRay, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00+$0.00 (0.0%)
Caliber Imaging & Diagnostics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 62.5% below the high.
$0.00$0.00 (0.0%)
Lombard Medical, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Regnum Corp.: Communication Services · Entertainment.
$0.00$0.00 (0.0%)
Greenwind Holdings Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Cotinga Pharmaceuticals Inc.: Healthcare · Biotechnology.
$0.00$0.00 (0.0%)
Urologix, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.21% below the high.
